⌘K

Login Start Free

Home/Filings/4/0001209191-22-043869

4//SEC Filing

Bessen Laura 4

Accession 0001209191-22-043869

CIK 0001662579other

View on SEC.gov Company Profile

Filed

Aug 1, 8:00 PM ET

Accepted

Aug 2, 4:23 PM ET

Size

5.3 KB

Accession

0001209191-22-043869

Insider Transaction Report

Form 4

Period: 2022-07-29

C4 Therapeutics, Inc.CCCC

Director

Transactions

Award
Stock Option (Right to Buy)
2022-07-29+41,200→ 41,200 total
Exercise: $9.64Exp: 2032-07-28→ Common Stock (41,200 underlying)

Footnotes (1)

[F1]One-third of the shares underlying this option shall vest and become exercisable on July 29, 2023, with the remainder vesting in eight equal quarterly installments thereafter.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

C4 Therapeutics, Inc.

CIK 0001662579

Entity typeother

Related Parties

1

filerCIK 0001926815

Filing Metadata

Form type: 4
Filed: Aug 1, 8:00 PM ET
Accepted: Aug 2, 4:23 PM ET
Size: 5.3 KB

View on SEC.gov